These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1827978)

  • 1. Functional consequences of cardiac hypertrophy and dilatation.
    Jacob R; Brändle M; Dierberger B; Rupp H
    Basic Res Cardiol; 1991; 86 Suppl 1():113-30. PubMed ID: 1827978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional significance of contractile proteins in cardiac hypertrophy and failure.
    Jacob R; Kissling G; Rupp H; Vogt M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S2-12. PubMed ID: 2485026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load.
    Friberg P
    Acta Physiol Scand Suppl; 1985; 540():1-47. PubMed ID: 3161269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is secondary myocardial hypertrophy a physiological or pathological adaptive mechanism?].
    Krayenbühl HP
    Z Kardiol; 1982 Aug; 71(8):489-96. PubMed ID: 6215776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
    Klaus D
    Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphologic findings during regression of heart hypertrophy].
    Frenzel H
    Z Kardiol; 1985; 74 Suppl 7():107-18. PubMed ID: 2936013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Left ventricular hypertrophy: favorable or unfavorable compensatory mechanisms?].
    Riegger AJ
    Herz; 1991 Sep; 16 Spec No 1():330-3. PubMed ID: 1840298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulation of cardiac output;an approximation at 3 levels: organic, cellular, and protein].
    Martíenz Caro D; Rodríguez García JA; Munguía L
    Rev Med Univ Navarra; 1999; 43(1):29-40. PubMed ID: 10386344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myocardial hypertrophy and arterial hypertension].
    Trevi G; Sheiban I; Gorni R
    G Ital Cardiol; 1995 Oct; 25(10):1331-8. PubMed ID: 8682229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanics of left ventricular systolic and diastolic function in physiologic hypertrophy of the athlete heart.
    Colan SD
    Cardiol Clin; 1992 May; 10(2):227-40. PubMed ID: 1533564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologic versus pathologic hypertrophy and the pressure-overloaded myocardium.
    Weber KT; Clark WA; Janicki JS; Shroff SG
    J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S37-50. PubMed ID: 2485029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered cardiac mechanism and sarcoplasmic reticulum function in pressure overload-induced cardiac hypertrophy in rats.
    Ohkusa T; Hisamatsu Y; Yano M; Kobayashi S; Tatsuno H; Saiki Y; Kohno M; Matsuzaki M
    J Mol Cell Cardiol; 1997 Jan; 29(1):45-54. PubMed ID: 9040020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course alterations of myocardial endothelin-1 production during the formation of exercise training-induced cardiac hypertrophy.
    Iemitsu M; Maeda S; Otsuki T; Goto K; Miyauchi T
    Exp Biol Med (Maywood); 2006 Jun; 231(6):871-5. PubMed ID: 16741015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional description of the left ventricle in patients with volume overload, pressure overload, and myocardial disease using cine magnetic resonance imaging.
    Wagner S; Auffermann W; Buser P; Semelka RC; Higgins CB
    Am J Card Imaging; 1991 Jun; 5(2):87-97. PubMed ID: 10147590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of right ventricular hypertrophy on cardiac performance and the relation between right ventricular systolic peak pressure and end-systolic volume.
    Seibold H; Grossman G; Wieshammer S; Adam WE; Stauch M
    Clin Physiol Biochem; 1987; 5(1):27-37. PubMed ID: 2953517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of systolic ventricular muscle function in man: the end systolic index.
    Spann JF; Carabello BA; Gash AK; Denenberg BS; Donner RM; Maurer AH; Malmud LS; Siegel JA
    Herz; 1984 Oct; 9(5):255-69. PubMed ID: 6238885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role of fatty acid oxidation in cardiac hypertrophy.
    Bressler R; Goldman S
    Cardioscience; 1993 Sep; 4(3):133-42. PubMed ID: 8400020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in left ventricular function and mass during serial investigations after valve replacement for aortic stenosis.
    Lund O; Erlandsen M
    J Heart Valve Dis; 2000 Jul; 9(4):583-93. PubMed ID: 10947054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal preload adjustment of maximal ventricular power index varies with cardiac chamber size.
    Nakayama M; Chen CH; Nevo E; Fetics B; Wong E; Kass DA
    Am Heart J; 1998 Aug; 136(2):281-8. PubMed ID: 9704691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.